Propofol and Dexmedetomidine Ameliorate Endotoxemia-Associated Encephalopathy via Inhibiting Ferroptosis
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Background: Sepsis is recognized as a multiorgan and systemic damage caused by dysregulated host response to infection. Its acute systemic inflammatory response highly resembles that of lipopolysaccharide (LPS)-induced endotoxemia. Propofol and dexmedetomidine are two commonly used sedatives for mechanical ventilation in critically ill patients and have been reported to alleviate cognitive impairment in many diseases. In this study, we aimed to explore and compare the effects of propofol and dexmedetomidine on the encephalopathy induced by endotoxemia and to investigate whether ferroptosis is involved, finally providing experimental evidence for multi-drug combination in septic sedation. Methods: A total of 218 C57BL/6J male mice (20– 25 g, 6– 8 weeks) were used. Morris water maze (MWM) tests were performed to evaluate whether propofol and dexmedetomidine attenuated LPS-induced cognitive deficits. Brain injury was evaluated using Nissl and Fluoro-Jade C (FJC) staining. Neuroinflammation was assessed by dihydroethidium (DHE) and DCFH-DA staining and by measuring the levels of three cytokines. The number of Iba1 + and GFAP + cells was used to detect the activation of microglia and astrocytes. To explore the involvement of ferroptosis, the levels of ptgs2 and chac1 ; the content of iron, malondialdehyde (MDA), and glutathione (GSH); and the expression of ferroptosis-related proteins were investigated. Conclusion: The single use of propofol and dexmedetomidine mitigated LPS-induced cognitive impairment, while the combination showed poor performance. In alleviating endotoxemic neural loss and degeneration, the united sedative group exhibited the most potent capability. Both propofol and dexmedetomidine inhibited neuroinflammation, while propofol’s effect was slightly weaker. All sedative groups reduced the neural apoptosis, inhibited the activation of microglia and astrocytes, and relieved neurologic ferroptosis. The combined group was most prominent in combating genetic and biochemical alterations of ferroptosis. Fpn1 may be at the core of endotoxemia-related ferroptosis activation. Keywords: propofol, dexmedetomidine, endotoxemia, encephalopathy, ferroptosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pharmacological synergy studies demonstrate that propofol combined with dexmedetomidine achieves multi-target intervention by regulating the Fpn1 node, reducing FTH1 expression by 58% and MDA levels by 41%, while reversing iron transporter abnormalities [92].”
From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pharmacological synergy studies demonstrate that propofol combined with dexmedetomidine achieves multi-target intervention by regulating the Fpn1 node, reducing FTH1 expression by 58% and MDA levels by 41%, while reversing iron transporter abnormalities [92].”
From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [92]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Pharmacological synergy studies demonstrate that propofol combined with dexmedetomidine achieves multi-target intervention by regulating the Fpn1 node, reducing FTH1 expression by 58% and MDA levels by 41%, while reversing iron transporter abnormalities [92].”
From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Xue, W., Li, Y., & Zhang, M. (2021) · Pharmaceutical Biology · doi:10.1080/13880209.2021.1981399 · Cited by 18
RetractedThe third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Ferroptosis: molecular mechanisms and health implications
Tang, D., Chen, X., Kang, R., & Kroemer, G. (2021) · Cell Research · doi:10.1038/s41422-020-00441-1 · Cited by 4,256
Devlin, J. W., Skrobik, Y., Gélinas, C., Needham, D. M., Slooter, A. J. C., Pandharipande, P. P., Watson, P. L., Weinhouse, G. L., Nunnally, M. E., Rochwerg, B., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003299 · Cited by 3,956
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
Dodson, M., Castro-Portuguez, R., & Zhang, D. D. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101107 · Cited by 2,435
Ferroptosis: machinery and regulation
Chen, X., Li, J., Kang, R., Klionsky, D. J., & Tang, D. (2021) · Autophagy · doi:10.1080/15548627.2020.1810918 · Cited by 2,099
van der Poll, T., Shankar-Hari, M., & Wiersinga, W. J. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.012 · Cited by 1,010
Transferrin Receptor Is a Specific Ferroptosis Marker
Feng, H., Schorpp, K., Jin, J., Yozwiak, C. E., Hoffstrom, B. G., Decker, A. M., Rajbhandari, P., Stokes, M. E., Bender, H. G., Csuka, J. M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.049 · Cited by 880
Mechanisms controlling cellular and systemic iron homeostasis
Galy, B., Conrad, M., & Muckenthaler, M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00648-1 · Cited by 785
The Pathogenesis of Sepsis and Potential Therapeutic Targets
Huang, M., Cai, S., & Su, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215376 · Cited by 776 · cited 1×
“36 Therefore, we assessed the effects of propofol and dexmedetomidine on LPS-induced systemic acute inflammation in vivo and in vitro.”
Background
Research works printed but not linked: 2
- Huang, 2019, Int J Mol Sci, 20, 21
- Chen, 2022, Cells, 11, 19
Cited by
Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy
Tan, H., Su, W., & Niu, Z. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125390 · Cited by 1
“Pharmacological synergy studies demonstrate that propofol combined with dexmedeto-midine achieves multi-target intervention by regulating the Fpn1 node, reducing FTH1 expression by 58% and MDA levels by 41%, while reversing iron transporter abnormalities [92].”
Metadata
- Authors
- Zhou, Y., Yang, Y., Yi, L., Pan, M., Tang, W., & Duan, H.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Zhou, Ye
- Yang, Yangliang
- Pan, Mengzhi
- Tang, Weiqing
- Duan, Hongwei
- Venue
- Drug Design, Development and Therapy
- Publisher
- Informa UK Limited
- Published
- 2024-04
- Volume
- Volume 18
- Pages
- 1349-1368
- ISSN
- 1177-8881 (ISSN-L)
- PMC
- PMC11055548
- OpenAlex
- W4395052200
- Cited by
- 13
- References
- 57
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 1
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Drug Design Development and Therapy (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (acceptedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Anesthesia and Neurotoxicity Research
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- propofol, dexmedetomidine, endotoxemia, sepsis, encephalopathy, ferroptosis, lipopolysaccharide, neuroinflammation, cognitive impairment, microglial activation, astrocytes, ferroportin 1, combination sedation, oxidative stress, neuroprotection, malondialdehyde, glutathione
- MeSH terms
- Ferroptosis, Animals, Brain Diseases, Dose-Response Relationship, Drug, Hypnotics and Sedatives, Lipopolysaccharides, Male, Mice, Inbred C57BL, Propofol, Endotoxemia, Dexmedetomidine, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.